WO2007000662A3 - Nouvelle composition de propofol comprenant de l'acide ascorbique ou des sels pharmaceutiquement acceptables de ce dernier - Google Patents

Nouvelle composition de propofol comprenant de l'acide ascorbique ou des sels pharmaceutiquement acceptables de ce dernier Download PDF

Info

Publication number
WO2007000662A3
WO2007000662A3 PCT/IB2006/001898 IB2006001898W WO2007000662A3 WO 2007000662 A3 WO2007000662 A3 WO 2007000662A3 IB 2006001898 W IB2006001898 W IB 2006001898W WO 2007000662 A3 WO2007000662 A3 WO 2007000662A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutically acceptable
acceptable salts
ascorbic acid
propofol composition
novel propofol
Prior art date
Application number
PCT/IB2006/001898
Other languages
English (en)
Other versions
WO2007000662A2 (fr
Inventor
Suresh Dixit
Sandhya Goyal
Frederick Okech
Efraim Shek
Original Assignee
Taro Pharmaceuticals Usa Inc
Suresh Dixit
Sandhya Goyal
Frederick Okech
Efraim Shek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharmaceuticals Usa Inc, Suresh Dixit, Sandhya Goyal, Frederick Okech, Efraim Shek filed Critical Taro Pharmaceuticals Usa Inc
Priority to EP06795088A priority Critical patent/EP1850829A4/fr
Publication of WO2007000662A2 publication Critical patent/WO2007000662A2/fr
Publication of WO2007000662A3 publication Critical patent/WO2007000662A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques stériles destinées à l'administration parentérale qui contiennent du 2,6-diisopropylphénol (propofol) et qui sont utilisées en tant qu'anesthésiques. Les compositions comprennent une émulsion 'huile en eau' de propofol et comprennent en outre une certaine quantité d'acide ascorbique ou de ses sels pharmaceutiquement acceptables, suffisante pour empêcher la croissance significative de micro-organismes pendant au moins 24 heures après la contamination accidentelle.
PCT/IB2006/001898 2005-02-03 2006-02-01 Nouvelle composition de propofol comprenant de l'acide ascorbique ou des sels pharmaceutiquement acceptables de ce dernier WO2007000662A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06795088A EP1850829A4 (fr) 2005-02-03 2006-02-01 Nouvelle composition de propofol comprenant de l'acide ascorbique ou des sels pharmaceutiquement acceptables de ce dernier

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64977705P 2005-02-03 2005-02-03
US60/649,777 2005-02-03

Publications (2)

Publication Number Publication Date
WO2007000662A2 WO2007000662A2 (fr) 2007-01-04
WO2007000662A3 true WO2007000662A3 (fr) 2009-04-09

Family

ID=37595501

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/001898 WO2007000662A2 (fr) 2005-02-03 2006-02-01 Nouvelle composition de propofol comprenant de l'acide ascorbique ou des sels pharmaceutiquement acceptables de ce dernier

Country Status (3)

Country Link
US (1) US20070293586A1 (fr)
EP (1) EP1850829A4 (fr)
WO (1) WO2007000662A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6392883B2 (ja) * 2014-09-25 2018-09-19 富士フイルム株式会社 プロポフォール含有水中油型エマルション組成物及びその製造方法
CN105616350A (zh) * 2014-10-28 2016-06-01 华仁药业股份有限公司 一种丙泊酚中/长链脂肪乳注射液的制备方法
CN104622806B (zh) * 2015-02-04 2018-03-16 北京蓝丹医药科技有限公司 一种丙泮尼地药物组合物及其制备方法
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714520A (en) * 1994-03-22 1998-02-03 Zeneca Limited Propofol compostion containing edetate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US6013632A (en) * 1997-01-13 2000-01-11 Emory University Compounds and their combinations for the treatment of influenza infection
AU742221B2 (en) * 1997-05-12 2001-12-20 Wisconsin Alumni Research Foundation Continuous crystallization system with controlled nucleation for milk fat fractionation
BR9907832A (pt) * 1998-02-10 2000-10-31 Sicor Inc Composição de propofol contendo sulfito
US6150423A (en) * 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6028108A (en) * 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
JP2006504771A (ja) * 2002-10-29 2006-02-09 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド システインを伴うプロポフォール
EP1500394A1 (fr) * 2003-07-22 2005-01-26 Polichem S.A. Compositions pharmaceutiques contenant de l'acide ascorbique pour le traitement de superinfections fongiques et les récurrence d'infections fongiques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714520A (en) * 1994-03-22 1998-02-03 Zeneca Limited Propofol compostion containing edetate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ELLER ET AL.: "Sporicidal Action of Auto-oxidized Ascorbic acid for Clostridium.", APPLIED MICROBIOLOGY., vol. 16, no. 2, February 1968 (1968-02-01), pages 349 - 354, XP008125471 *
See also references of EP1850829A4 *

Also Published As

Publication number Publication date
EP1850829A4 (fr) 2012-12-26
US20070293586A1 (en) 2007-12-20
EP1850829A2 (fr) 2007-11-07
WO2007000662A2 (fr) 2007-01-04

Similar Documents

Publication Publication Date Title
CA2319810A1 (fr) Composition a base de propofol contenant du sulfite
DK1163007T3 (da) TRIS-holdige propofol-formuleringer
WO2007118198A8 (fr) ANALOGUES DE LA 2-MÉTHYLÈNE-1α,25-DIHYDROXY-19,21-DINOR-VITAMINE D3 ET LEURS UTILISATIONS
MX2011012122A (es) Derivados de tiofeno.
UA94901C2 (ru) Антибактериальные производные пиперидина
EP2263667A3 (fr) Compositions comprenant du trans-(+/-)-delta-9-tetrahydrocannabinol cristallin
WO2007082808A3 (fr) Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1
WO2006099941A8 (fr) 8-n-benzimidazoles a substitution aminocarbonyle, leur procede de production, et leur utilisation en tant que medicaments
UA95715C2 (ru) Фосфадиазиновые производные, фармацевтическая композиция и их применение
EP2168957A3 (fr) Tétrahydropyrane substitué par alkyl en tant qu'arome
MX2009013501A (es) Compuestos piperidinicos y sus usos.
MA29653B1 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2006063039A3 (fr) 3,6-bicyclolides
WO2004096823A3 (fr) Nouveaux derives de ketolides
MA31142B1 (fr) Derives heteroaryles de pyrrolidinyl et piperdinyl cetones.
WO2007000662A3 (fr) Nouvelle composition de propofol comprenant de l'acide ascorbique ou des sels pharmaceutiquement acceptables de ce dernier
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
WO2010105951A3 (fr) Composition comprenant la combinaison de madécassoside, d'une arginine et de polysorbate
BRPI0515181A (pt) composição de óleo-em-água estéril para administração intravenosa, uso de um monoglicerìdeo e processo de preparação de uma composição para administração intravenosa
WO2004100935A3 (fr) Formulation de propofol contenant de l'huile reduite et des tensioactifs
MX2009004295A (es) Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa.
MX2010006215A (es) Derivados de piperazina y su uso como moduladores del receptor de leptina.
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
DE602004018647D1 (de) Galloylpeptide
MX2010006216A (es) Nuevos compuestos iii.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006795088

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2006795088

Country of ref document: EP